100 related articles for article (PubMed ID: 1891764)
1. A colourimetric enzyme-linked sandwich assay for the detection of human platelets bound to a fibrinogen-coated surface.
Nieman CJ; Kerry R; Coleman PJ; Taylor A; Jose J; Pay GF
Thromb Res; 1991 May; 62(3):189-97. PubMed ID: 1891764
[TBL] [Abstract][Full Text] [Related]
2. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
[TBL] [Abstract][Full Text] [Related]
3. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
5. An echistatin C-terminal peptide activates GPIIbIIIa binding to fibrinogen, fibronectin, vitronectin and collagen type I and type IV.
Wright PS; Saudek V; Owen TJ; Harbeson SL; Bitonti AJ
Biochem J; 1993 Jul; 293 ( Pt 1)(Pt 1):263-7. PubMed ID: 7687129
[TBL] [Abstract][Full Text] [Related]
6. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
[TBL] [Abstract][Full Text] [Related]
7. Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen.
Hato T; Ikeda K; Yasukawa M; Watanabe A; Kobayashi Y
Blood; 1988 Jul; 72(1):224-9. PubMed ID: 2455569
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet "hybrid" peptides analogous to receptor recognition domains on gamma and alpha chains of human fibrinogen.
Timmons S; Bednarek MA; Kloczewiak M; Hawiger J
Biochemistry; 1989 Apr; 28(7):2919-23. PubMed ID: 2742820
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
Foster MR; Hornby EJ; Brown S; Hann M; Kitchin J; Pike N; Ward P
Thromb Res; 1994 Aug; 75(3):269-84. PubMed ID: 7992238
[TBL] [Abstract][Full Text] [Related]
10. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
[TBL] [Abstract][Full Text] [Related]
11. An antiplatelet peptide, gabonin, from Bitis gabonica snake venom.
Huang TF; Peng HC; Peng IS; Teng CM; Ouyang C
Arch Biochem Biophys; 1992 Oct; 298(1):13-20. PubMed ID: 1524422
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.
Pidard D; Frelinger AL; Bouillot C; Nurden AT
Eur J Biochem; 1991 Sep; 200(2):437-47. PubMed ID: 1889410
[TBL] [Abstract][Full Text] [Related]
13. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.
Huang TF; Sheu JR; Teng CM
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):351-7. PubMed ID: 1859363
[TBL] [Abstract][Full Text] [Related]
14. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
Foster MR; Hornby EJ; Brown S; Kitchin J; Hann M; Ward P
Thromb Res; 1993 Nov; 72(3):231-45. PubMed ID: 8303662
[TBL] [Abstract][Full Text] [Related]
15. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
16. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical localization of platelets in baboon hepatic sinusoids using monoclonal mouse anti-human platelet glycoprotein IIIa following induction of thrombocytopenia.
Frank JD; Gould RJ; Schaffer LW; Davidson JT; Gibson RE; Patrick DH; Vonderfecht SL; Cartwright ME
Histochemistry; 1992 May; 97(4):355-60. PubMed ID: 1618650
[TBL] [Abstract][Full Text] [Related]
18. Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
Bernabei A; Gikakis N; Kowalska MA; Niewiarowski S; Edmunds LH
Ann Thorac Surg; 1995 Jan; 59(1):149-53. PubMed ID: 7529485
[TBL] [Abstract][Full Text] [Related]
19. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules.
Handagama P; Bainton DF; Jacques Y; Conn MT; Lazarus RA; Shuman MA
J Clin Invest; 1993 Jan; 91(1):193-200. PubMed ID: 8423218
[TBL] [Abstract][Full Text] [Related]
20. Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces.
Jen CJ; Lin JS
Am J Physiol; 1991 Nov; 261(5 Pt 2):H1457-63. PubMed ID: 1951733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
